phenytoin has been researched along with Neurocysticercosis in 18 studies
Neurocysticercosis: Infection of the brain, spinal cord, or perimeningeal structures with the larval forms of the genus TAENIA (primarily T. solium in humans). Lesions formed by the organism are referred to as cysticerci. The infection may be subacute or chronic, and the severity of symptoms depends on the severity of the host immune response and the location and number of lesions. SEIZURES represent the most common clinical manifestation although focal neurologic deficits may occur. (From Joynt, Clinical Neurology, 1998, Ch27, pp46-50)
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the response to albendazole treatment in patients who had SSECTL and new onset seizures treated with antiepileptic drugs (AED) in a prospective clinical trial." | 9.13 | Albendazole therapy for single small enhancing CT lesions (SSECTL) in the brain in epilepsy. ( Chattopadhyay, A; Khandelwal, N; Sawhney, IM; Thussu, A, 2008) |
| "To determine the safety and efficacy (measured by the incidence of 'treatment failure') of clobazam in comparison to standard treatment with phenytoin-sodium for prevention of seizures in persons with solitary cysticercus granulomas (SCGs)." | 9.12 | Safety and efficacy of clobazam versus phenytoin-sodium in the antiepileptic drug treatment of solitary cysticercus granulomas. ( Chopra, SC; Kaushal, S; Rani, A; Singh, G, 2006) |
| "Albendazole plus dexamethasone increased complete or partial resolution of lesions and reduced the risk of subsequent recurrence of seizures among children with neurocysticercosis who had with seizures and 1 or 2 ring-enhancing lesions on computed tomography." | 9.10 | Efficacy of albendazole and short-course dexamethasone treatment in children with 1 or 2 ring-enhancing lesions of neurocysticercosis: a randomized controlled trial. ( Dua, T; Kalra, V; Kumar, V, 2003) |
| " The pharmacokinetic parameters were analyzed by analysis of variance followed by the Tukey-Kramer test." | 6.70 | Pharmacokinetic interaction between albendazole sulfoxide enantiomers and antiepileptic drugs in patients with neurocysticercosis. ( Dreossi, SA; Garcia, FS; Lanchote, VL; Takayanagui, OM, 2002) |
| "To evaluate the response to albendazole treatment in patients who had SSECTL and new onset seizures treated with antiepileptic drugs (AED) in a prospective clinical trial." | 5.13 | Albendazole therapy for single small enhancing CT lesions (SSECTL) in the brain in epilepsy. ( Chattopadhyay, A; Khandelwal, N; Sawhney, IM; Thussu, A, 2008) |
| "To determine the safety and efficacy (measured by the incidence of 'treatment failure') of clobazam in comparison to standard treatment with phenytoin-sodium for prevention of seizures in persons with solitary cysticercus granulomas (SCGs)." | 5.12 | Safety and efficacy of clobazam versus phenytoin-sodium in the antiepileptic drug treatment of solitary cysticercus granulomas. ( Chopra, SC; Kaushal, S; Rani, A; Singh, G, 2006) |
| "Albendazole plus dexamethasone increased complete or partial resolution of lesions and reduced the risk of subsequent recurrence of seizures among children with neurocysticercosis who had with seizures and 1 or 2 ring-enhancing lesions on computed tomography." | 5.10 | Efficacy of albendazole and short-course dexamethasone treatment in children with 1 or 2 ring-enhancing lesions of neurocysticercosis: a randomized controlled trial. ( Dua, T; Kalra, V; Kumar, V, 2003) |
| " Carbamazepine or oxcarbazepine are best suited for seizure prophylaxis for those who present with seizures; phenytoin and levetiracetam are the other alternatives." | 4.02 | Management of Neurocysticercosis in Children: Association of Child Neurology Consensus Guidelines. ( Kadwa, RA; Kamate, M; Kannan, L; Kumar, A; Passi, GR; Sankhyan, N; Sharawat, IK; Singhi, P, 2021) |
| " The aim of this study was to study the frequency and nature of cutaneous reactions in a cohort of patients being treated with phenytoin sodium for seizures, who were divided into those with a solitary cysticercus granuloma (SCG) and those with a condition other than SCG, to determine if the presence of SCG increases the risk of cutaneous adverse reaction to phenytoin." | 3.72 | Cutaneous reactions in patients with solitary cysticercus granuloma on phenytoin sodium. ( Chander Chopra, S; Gupta, M; Kaushal, S; Singh, G, 2004) |
| " The pharmacokinetic parameters were analyzed by analysis of variance followed by the Tukey-Kramer test." | 2.70 | Pharmacokinetic interaction between albendazole sulfoxide enantiomers and antiepileptic drugs in patients with neurocysticercosis. ( Dreossi, SA; Garcia, FS; Lanchote, VL; Takayanagui, OM, 2002) |
| "Epilepsy is the commonest clinical presentation, though it may also present with headache, symptoms of raised intracranial tension, hydrocephalus and ocular symptoms depending upon the localisation of the parasitic cysts." | 2.52 | Antiepileptic drugs for seizure control in people with neurocysticercosis. ( Mathew, A; Sharma, M; Singh, T, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.56) | 18.2507 |
| 2000's | 11 (61.11) | 29.6817 |
| 2010's | 5 (27.78) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Sankhyan, N | 1 |
| Kadwa, RA | 1 |
| Kamate, M | 1 |
| Kannan, L | 1 |
| Kumar, A | 1 |
| Passi, GR | 1 |
| Sharawat, IK | 1 |
| Singhi, P | 1 |
| Khemka, P | 1 |
| Ray, S | 1 |
| Mukherjee, D | 1 |
| Sharma, M | 1 |
| Singh, T | 1 |
| Mathew, A | 1 |
| Tan, TC | 1 |
| de Boer, BW | 1 |
| Mitchell, A | 1 |
| Delriviere, L | 1 |
| Adams, LA | 1 |
| Jeffrey, GP | 1 |
| Macquillan, G | 1 |
| Burneo, JG | 1 |
| Plener, I | 1 |
| Garcia, HH | 1 |
| Sohrabi, F | 1 |
| Kaushal, S | 3 |
| Sharma, A | 1 |
| Singh, B | 1 |
| Kumar, V | 2 |
| Sharma, V | 1 |
| Sanjay, S | 1 |
| Koh, YT | 1 |
| Gan, NY | 1 |
| Vishnu, VY | 1 |
| Kesav, P | 1 |
| Prabhakar, S | 1 |
| Kalra, V | 1 |
| Dua, T | 1 |
| Singh, G | 2 |
| Gupta, M | 1 |
| Chander Chopra, S | 1 |
| Bowie, EM | 1 |
| Folk, JC | 1 |
| Barnes, CH | 1 |
| Menon, B | 1 |
| Arasu, K | 1 |
| Khairul, A | 1 |
| Waran, V | 1 |
| Rani, A | 1 |
| Chopra, SC | 1 |
| Thussu, A | 1 |
| Chattopadhyay, A | 1 |
| Sawhney, IM | 1 |
| Khandelwal, N | 1 |
| Yoo, JH | 1 |
| Kang, DS | 1 |
| Chun, WH | 1 |
| Lee, WJ | 1 |
| Lee, AK | 1 |
| Lanchote, VL | 1 |
| Garcia, FS | 1 |
| Dreossi, SA | 1 |
| Takayanagui, OM | 1 |
1 review available for phenytoin and Neurocysticercosis
| Article | Year |
|---|---|
Antiepileptic drugs for seizure control in people with neurocysticercosis.
Topics: Adolescent; Adult; Anticonvulsants; Brain Diseases; Carbamazepine; Child; Child, Preschool; Epilepsy | 2015 |
4 trials available for phenytoin and Neurocysticercosis
| Article | Year |
|---|---|
Efficacy of albendazole and short-course dexamethasone treatment in children with 1 or 2 ring-enhancing lesions of neurocysticercosis: a randomized controlled trial.
Topics: Adolescent; Albendazole; Anthelmintics; Anti-Inflammatory Agents; Anticonvulsants; Brain; Brain Edem | 2003 |
Safety and efficacy of clobazam versus phenytoin-sodium in the antiepileptic drug treatment of solitary cysticercus granulomas.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Benzodiazepines; Child, Preschool; Clobazam; Double-Blind | 2006 |
Albendazole therapy for single small enhancing CT lesions (SSECTL) in the brain in epilepsy.
Topics: Adolescent; Adult; Albendazole; Anthelmintics; Carbamazepine; Cerebral Cortex; Child; Child, Prescho | 2008 |
Pharmacokinetic interaction between albendazole sulfoxide enantiomers and antiepileptic drugs in patients with neurocysticercosis.
Topics: Adult; Albendazole; Anthelmintics; Anticonvulsants; Area Under Curve; Carbamazepine; Chromatography, | 2002 |
13 other studies available for phenytoin and Neurocysticercosis
| Article | Year |
|---|---|
Management of Neurocysticercosis in Children: Association of Child Neurology Consensus Guidelines.
Topics: Albendazole; Child; Humans; Neurocysticercosis; Neurology; Phenytoin; Seizures | 2021 |
An unusual case of encephalitis with starry sky pattern in MRI.
Topics: Anticonvulsants; Antiparasitic Agents; Brain; Child, Preschool; Diagnosis, Differential; Disease Man | 2015 |
Levetiracetam as a possible cause of fulminant liver failure.
Topics: Adult; Anticonvulsants; Brain; Epilepsy; Humans; Levetiracetam; Liver; Liver Failure, Acute; Liver F | 2008 |
Neurocysticercosis in a patient in Canada.
Topics: Albendazole; Anti-Inflammatory Agents; Anticonvulsants; Antiprotozoal Agents; Brain; Brain Diseases; | 2009 |
Headache as the initial manifestation of neurocysticercosis: a case of eosinophilic meningitis.
Topics: Adult; Albendazole; Antibodies; Brain; Calcinosis; Dexamethasone; Eosinophilia; Headache; Humans; Im | 2009 |
Stars in the sky: neurocysticercosis.
Topics: Adult; Albendazole; Anthelmintics; Anticonvulsants; Diagnosis, Differential; Diuretics, Osmotic; Dru | 2012 |
A persistent red eye and diplopia--when to neuroimage?
Topics: Adult; Albendazole; Anthelmintics; Anticonvulsants; Dexamethasone; Diplopia; Female; Glucocorticoids | 2012 |
Disseminated cysticercosis.
Topics: Anticonvulsants; Cysticercosis; Drug Therapy, Combination; Glucocorticoids; Humans; Magnetic Resonan | 2013 |
Cutaneous reactions in patients with solitary cysticercus granuloma on phenytoin sodium.
Topics: Adult; Anticonvulsants; Drug Hypersensitivity; Exanthema; Female; Granuloma, Foreign-Body; Humans; M | 2004 |
Corticosteroids, central serous chorioretinopathy, and neurocysticercosis.
Topics: Adult; Albendazole; Anticonvulsants; Antiprotozoal Agents; Body Fluids; Combined Modality Therapy; D | 2004 |
Starry sky and beaded legs.
Topics: Adult; Albendazole; Anticestodal Agents; Anticonvulsants; Brain; Calcinosis; Female; Headache; Human | 2006 |
Neurocysticercosis an uncommon intra-cerebral infection in Malaysia.
Topics: Adult; Albendazole; Anthelmintics; Child; Female; Humans; Magnetic Resonance Imaging; Malaysia; Male | 2005 |
Anticonvulsant hypersensitivity syndrome with an epoxide hydrolase defect.
Topics: Anticonvulsants; Drug Hypersensitivity; Epilepsy; Humans; Male; Middle Aged; Neurocysticercosis; Phe | 1999 |